Rosalind Franklin University Researcher awarded NIH grant for CLN3 Batten disease study

Michelle Hastings, PhD, director of the Center for Genetic Diseases, is leading an NIH-funded team in the study of a new therapeutic approach for CLN3 Batten disease in children. Study published July 27 in Nature Medicine.